USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Biogrowth Inc.
Address:
3065 Atlas Road Suite 117
Richmond, CA 94806
Phone:
N/A
URL:
N/A
EIN:
N/A
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $200,000.00 4
SBIR Phase II $725,000.00 2

Award List:

REGULATION OF BIOLOGICAL GROWTH

Award Year / Program / Phase:
1986 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
E Martin Spencer , Principal Investigator
Abstract:
N/a

REGULATION OF BIOLOGICAL GROWTH

Award Year / Program / Phase:
1987 / SBIR / Phase II
Award Amount:
$500,000.00
Agency:
HHS
Principal Investigator:
E Martin Spencer , Principal Investigator
Abstract:
The long-term objective of this project is to be able to regulate abnormal growth processes that are related to somatomedins. as somatomedins are the major stimulators of bone formation, they offer promise in the therapy of post- menopausal osteoporosis. they may also be used to stimulatebone… More

MONOCLONAL ANTIBODIES TO A GROWTH REGULATOR

Award Year / Program / Phase:
1988 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Abstract:
A panel of monoclonal antibodies directed against a specificand important growth regulator is being developed. hybridomas will be isolated, characterized, and cloned. further characterization of the resultant monoclonal antibodies will be carried out to identify which will be most useful for (a)… More

IDENTIFICATZON OF TISSUE-SPECIFIC IGF-CP VARIANTS

Award Year / Program / Phase:
1989 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Abstract:
The ultimate goal of this project is to identify natural variants of the insulin-like growth-factor carrier protein (igf-cp) that exhibit enhanced therapeutic potential. such igf-cp's may only be synthesized in specific tissues where they interact with igf's to carry out particular functions. for… More

BOVINE IGF CARRIER PROTEIN TO ENHANCE GROWTH, MILK PRODUCTION, AND WOUND HEALING

Award Year / Program / Phase:
1990 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
USDA
Principal Investigator:
Dr Sharon K Spratt
Abstract:
N/a

BOVINE IGF CARRIER PROTEIN TO ENHANCE GROWTH, MILK PRODUCTION, AND WOUND HEALING

Award Year / Program / Phase:
1991 / SBIR / Phase II
Award Amount:
$225,000.00
Agency:
USDA
Principal Investigator:
Dr Sharon K Spratt
Abstract:
The overall goal of this project is to develop a novel, cost-effective carrier vehicle for bovine insulin-like growth factor (igf): the bovine igf carrier protein (bbp3).bbp3 will bind igf with high affinity, protect it from degradation, and slowly release it in an active form. therefore, bbp3 will… More